EULAR Journals
The EULAR Journals bring together the best of rheumatology research in two complementary platforms. The Annals of the Rheumatic Diseases (ARD), EULAR’s renowned flagship journal, shares high-impact studies and trusted guidance that shape everyday clinical practice. Alongside it, EULAR Rheumatology Open (ERO) offers a fresh, fully open-access space where anyone, anywhere, can explore new ideas and innovations in the field. Together, they make cutting-edge science more accessible, fostering collaboration and driving progress for the rheumatology community worldwide.
Annals of the Rheumatic Diseases (ARD)
Annals of the Rheumatic Diseases (ARD) is an international peer reviewed
journal committed to promoting the highest standards of scientific exchange and
education.
It is the leading rheumatology journal publishing a combination of
high-quality scientific papers, including original research, reviews,
recommendations, viewpoints, and more. Clinical, basic and translational
science across the inflammatory and non-inflammatory musculoskeletal conditions
are part and parcel of this spectrum.
ARD is an official journal of EULAR with an impact factor of 20.6.
EULAR Rheumatology Open (ERO)
EULAR has launched its new open-access journal, EULAR Rheumatology Open (ERO), a pioneering platform dedicated to advancing research and knowledge in the field of rheumatology. The journal offers an innovative, online-only space hosted by the globally renowned publisher Elsevier. ERO provides researchers, healthcare professionals, and the wider scientific community with immediate access to the latest advancements in rheumatology.
The new journal represents EULAR's commitment to fostering scientific excellence and promoting the dissemination of high-quality, peer-reviewed research. As an open-access journal, it ensures that cutting-edge studies, reviews, and insights are freely available to a global audience, furthering the reach and impact of rheumatology research across disciplines.
Latest News
- EULAR proudly announces the launch of its new open-access journal, EULAR Rheumatology Open (ERO), a pioneering platform dedicated to advancing research and knowledge in the field of rheumatology. The journal will be launched in January 2025. offering an innovative, online-only space hosted by the globally renowned publisher Elsevier. ERO will provide researchers, healthcare professionals, and the wider scientific community with immediate access to the latest advancements in rheumatology.
Read the EULAR Press Release here - EULAR announces a new partnership with Elsevier, a global leader in information and analytics, to publish its flagship scientific journal, Annals of the Rheumatic Diseases (ARD). The journal will be hosted on Elsevier’s leading online platform, ScienceDirect, beginning January 2025.
Read the EULAR Press Release here - EULAR and BMJ announce change of
ownership of leading rheumatology journals, Annals
of the Rheumatic Diseases (ARD) and RMD
Open. EULAR will take full
ownership of ARD, while BMJ will
wholly own RMD Open.
Read the joint announcement here
Related Videos
Related Information
ARD lay summaries for patients and non-clinicians
ARD provides short research summaries for patients and non-clinicians to accompany selected key research papers published in the journal. These aim to clearly explain the results of the research studies as well as any implications for treatment of the specific condition. The summaries are written in plain language in a consistently structured format and checked for accuracy and readability by expert rheumatologists and people from EULAR’s network of patient research partners.
Journals on social media
You can follow the journals on X and BlueSky, and listen to free occasional audio podcasts from ARD .